526139-BOM

The stock has been placed in Graded Surveillance Measure (GSM) list GSM - 0.

Transgene Biotek Ltd.

BSE: 526139

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

3.10+0.0 (+0.98%)

17 Jul, 11:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

22.96

P/E (TTM)

P/B

P/S (TTM)

108.70

EV/EBITDA

CAPE (5Y)

ROE (TTM)

ROCE (TTM)

ROA (TTM)

Avg 3Y ROE

Earnings 3Y CAGR

34.96

Sales 3Y CAGR

56.52

Sales 5Y CAGR

4.49

Debt/Equity

Consensus TP

Strong Buy %

Promoter Holding

23.64

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Transgene Biotek Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Consistently pays dividend

The company has not missed dividend payments once in the last 10 financial years

What is Dividend streak?

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -7.2% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of -18.99% for 12-month ended 31 Mar 2026 and the growth was 32.55 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 13.56

Value -18.99

-97.35238.8

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -144.62% for 12-month ended 31 Mar 2026 and the growth was 145.76 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Transgene Biotek Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Transgene Biotek Ltd. Shareholding Pattern

Quarterly breakdown of Transgene Biotek Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64
Indian Promoter	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64	23.64
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36	76.36
Bodies Corporate	1.35	1.23	1.27	1.08	0.99	1.02	0.71	0.76	0.72	0.70	0.69	0.69	0.68	0.78	0.69	2.53	1.14	0.82	0.82	0.79	0.77	0.77	0.74	0.74	0.74	0.74
Others (incl. Retail) No. of shareholders	75.01 10,314	75.13 10,380	75.09 10,227	75.28 10,183	75.37 10,245	75.34 10,682	75.65 10,711	75.60 11,045	75.64 11,234	75.66 11,248	75.67 11,221	75.67 11,352	75.68 11,297	75.58 11,270	75.67 11,291	73.83 12,144	75.22 12,353	75.54 12,696	75.54 12,897	75.57 13,242	75.59 13,518	75.59 13,410	75.62 13,397	75.62 13,481	75.62 13,704	75.62 13,754

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Transgene Biotek Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

Corporate Actions

History of Transgene Biotek Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Rights Issue(3 new shares @ ₹20 for 5 existing shares)
Ex-date: 13th Jan 1995Announced on: 12th Jan 1995

Company Profile

Overview of Transgene Biotek Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Transgene Biotek Limited is an India-based biotechnology company. It is engaged in the research and development of vaccines, oncology, and new drug delivery technologies. Its portfolio of products includes oncology, autoimmunity, drug delivery and biogenetics. The Company offers TrabiAAV, which is a...

Key personnel

Dr. K. Koteswara Rao

Managing Director

Shyam Shankar DasD

Director

Shri. Vikram PolavarapuD

Additional Director

Shri. Sarang Subhash PuranikD

Director

Dr. P. K. GhoshD

Independent Director

Shri. Soma Sekhar MarthiD

Independent Director

Smt. L. SujanaD

Independent Director

Shri. G. Santosh KumarD

Additional Non-Executive Independent Director

Incorporated on

01 Mar 1990

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

23 Sep 1992

Free Float

5,93,42,098

Website

https://www.transgenebiotek.com/

Phone no.

+918458279744

Address

Plot 68,69,70, Anrich Industrial Area, Bollaram,, MEDAK, 502325, India

Frequently Asked Questions

What is the current share price of Transgene Biotek Ltd.?

The current share price of Transgene Biotek Ltd. is ₹ 3.10 as of 17 Jul 2026.

What is the market capitalisation of Transgene Biotek Ltd.?

The market capitalisation of Transgene Biotek Ltd. stands at ₹ 22.96 Cr.

What is the PE ratio of Transgene Biotek Ltd.?

The Price-to-Earnings (PE) ratio of Transgene Biotek Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Transgene Biotek Ltd.?

Transgene Biotek Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.

What is the 52-week high and low of Transgene Biotek Ltd.?

The 52-week high of Transgene Biotek Ltd. is - and the 52-week low is -.

What is the dividend yield of Transgene Biotek Ltd.?

The dividend yield of Transgene Biotek Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Transgene Biotek Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 75.62% of Transgene Biotek Ltd. shares.

What sector does Transgene Biotek Ltd. belong to?

Transgene Biotek Ltd. operates in the Healthcare sector.

What is the beta of Transgene Biotek Ltd.?

The beta of Transgene Biotek Ltd. is 1.00, indicating its price volatility relative to the broader market. Over the past 1 year, Transgene Biotek Ltd. has delivered an absolute return of -37.53%.

What is the RSI of Transgene Biotek Ltd.?

The 14-day Relative Strength Index (RSI) of Transgene Biotek Ltd. is 48.85, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Transgene Biotek Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Transgene Biotek Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Company Profile

Stock Analysis

Corporate Actions